APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mycoprotein

Mycoprotein is a protein made from Fusarium venenatum, a naturally occurring fungus.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Mycoprotein is a protein made from Fusarium venenatum, a naturally occurring fungus.

Selected research

Market Outlook & Growth Opportunities

Global Mycoprotein Market Outlook and Growth Opportunities 2026

28 December 2025197 pages

Choose your research edition.

Industry ResearchMycoprotein Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Mycoprotein Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Mycoprotein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mycoprotein Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Mycoprotein Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Mycoprotein is a protein made from Fusarium venenatum, a naturally occurring fungus.

Mycoprotein is mainly used in the following applications: meat alternatives, pet food, feed. Meat alternatives were the most widely used group, accounting for about 62 percent of the Japanese market in 2019.

The main categories are food grade and feed grade. Food-grade Mycoprotein accounted for about 98% of the Japanese market in 2019

Read the full market overview

Quorn/Monde Nissin Corporation, 3FBIO Ltd and Mycorena are all major players in the Mycoprotein market in Japan.

This report provides an overview of the global Mycoprotein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mycoprotein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mycoprotein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mycoprotein market size, projected growth trends, production technologies, key applications, and end-use industries.

Mycoprotein Segment by Company

Quorn/Monde Nissin Corporation

3fbio Ltd

Mycorena

Mycoprotein Segment by Type

Food Grade Mycoprotein

Feed Grade Mycoprotein

Mycoprotein Segment by Application

Meat Alternatives

Pet Food

Feed

Mycoprotein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mycoprotein status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Mycoprotein market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mycoprotein significant trends, drivers, influence factors in global and regions.

6. To analyze Mycoprotein competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mycoprotein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mycoprotein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mycoprotein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mycoprotein market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mycoprotein industry.

Chapter 3: Detailed analysis of Mycoprotein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Mycoprotein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Mycoprotein in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mycoprotein Industry Trends Table 2. Mycoprotein Industry Drivers Table 3. Mycoprotein Industry Opportunities and Challenges Table 4. Mycoprotein Industry Restraints Table 5. Global Mycoprotein Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mycoprotein Revenue Share by Company (2021-2026) Table 7. Global Mycoprotein Sales Volume by Company (MT) & (2021-2026) Table 8. Global Mycoprotein Sales Volume Share by Company (2021-2026) Table 9. Global Mycoprotein Average Price (USD/MT) of Company (2021-2026) Table 10. Global Mycoprotein Company Ranking, (2024-2026) & (USD Million) Table 11. Global Mycoprotein Key Company Manufacturing Base & Headquarters Table 12. Global Mycoprotein Company, Product Type & Application Table 13. Global Mycoprotein Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Mycoprotein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Food Grade Mycoprotein Table 18. Significant Companies of Feed Grade Mycoprotein Table 19. Global Mycoprotein Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 20. Global Mycoprotein Sales Volume by Type (2021-2026) & (MT) Table 21. Global Mycoprotein Sales Volume by Type (2027-2032) & (MT) Table 22. Global Mycoprotein Sales Volume Share by Type (2021-2026) Table 23. Global Mycoprotein Sales Volume Share by Type (2027-2032) Table 24. Global Mycoprotein Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Mycoprotein Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Mycoprotein Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Mycoprotein Sales Value Share by Type (2021-2026) Table 28. Global Mycoprotein Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Meat Alternatives Table 30. Significant Companies of Pet Food Table 31. Significant Companies of Feed Table 32. Global Mycoprotein Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 33. Global Mycoprotein Sales Volume by Application (2021-2026) & (MT) Table 34. Global Mycoprotein Sales Volume by Application (2027-2032) & (MT) Table 35. Global Mycoprotein Sales Volume Share by Application (2021-2026) Table 36. Global Mycoprotein Sales Volume Share by Application (2027-2032) Table 37. Global Mycoprotein Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Mycoprotein Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Mycoprotein Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Mycoprotein Sales Value Share by Application (2021-2026) Table 41. Global Mycoprotein Sales Value Share by Application (2027-2032) Table 42. Global Mycoprotein Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 43. Global Mycoprotein Sales by Region (2021-2026) & (MT) Table 44. Global Mycoprotein Sales Market Share by Region (2021-2026) Table 45. Global Mycoprotein Sales by Region (2027-2032) & (MT) Table 46. Global Mycoprotein Sales Market Share by Region (2027-2032) Table 47. Global Mycoprotein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Mycoprotein Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Mycoprotein Sales Value Share by Region (2021-2026) Table 50. Global Mycoprotein Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Mycoprotein Sales Value Share by Region (2027-2032) Table 52. Global Mycoprotein Market Average Price (USD/MT) by Region (2021-2026) Table 53. Global Mycoprotein Market Average Price (USD/MT) by Region (2027-2032) Table 54. Global Mycoprotein Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 55. Global Mycoprotein Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Mycoprotein Sales by Country (2021-2026) & (MT) Table 57. Global Mycoprotein Sales Market Share by Country (2021-2026) Table 58. Global Mycoprotein Sales by Country (2027-2032) & (MT) Table 59. Global Mycoprotein Sales Market Share by Country (2027-2032) Table 60. Global Mycoprotein Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Mycoprotein Sales Value Market Share by Country (2021-2026) Table 62. Global Mycoprotein Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Mycoprotein Sales Value Market Share by Country (2027-2032) Table 64. Quorn/Monde Nissin Corporation Company Information Table 65. Quorn/Monde Nissin Corporation Business Overview Table 66. Quorn/Monde Nissin Corporation Mycoprotein Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 67. Quorn/Monde Nissin Corporation Mycoprotein Product Portfolio Table 68. Quorn/Monde Nissin Corporation Recent Development Table 69. 3fbio Ltd Company Information Table 70. 3fbio Ltd Business Overview Table 71. 3fbio Ltd Mycoprotein Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 72. 3fbio Ltd Mycoprotein Product Portfolio Table 73. 3fbio Ltd Recent Development Table 74. Mycorena Company Information Table 75. Mycorena Business Overview Table 76. Mycorena Mycoprotein Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 77. Mycorena Mycoprotein Product Portfolio Table 78. Mycorena Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Mycoprotein Distributors List Table 82. Mycoprotein Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Mycoprotein Product Image Figure 2. Global Mycoprotein Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mycoprotein Sales Value (2021-2032) & (US$ Million) Figure 4. Global Mycoprotein Sales (2021-2032) & (MT) Figure 5. Global Mycoprotein Sales Average Price (USD/MT) & (2021-2032) Figure 6. Global Mycoprotein Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Food Grade Mycoprotein Image Figure 10. Feed Grade Mycoprotein Image Figure 11. Global Mycoprotein Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 12. Global Mycoprotein Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Mycoprotein Sales Volume Share by Type (2021-2032) Figure 14. Global Mycoprotein Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Mycoprotein Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Mycoprotein Sales Value Share by Type (2021-2032) Figure 17. Meat Alternatives Image Figure 18. Pet Food Image Figure 19. Feed Image Figure 20. Global Mycoprotein Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 21. Global Mycoprotein Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Mycoprotein Sales Volume Share by Application (2021-2032) Figure 23. Global Mycoprotein Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Mycoprotein Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Mycoprotein Sales Value Share by Application (2021-2032) Figure 26. Global Mycoprotein Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 27. Global Mycoprotein Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Mycoprotein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Mycoprotein Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Mycoprotein Sales Value (2021-2032) & (US$ Million) Figure 31. North America Mycoprotein Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Mycoprotein Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Mycoprotein Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Mycoprotein Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Mycoprotein Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Mycoprotein Sales Value (2021-2032) & (US$ Million) Figure 37. South America Mycoprotein Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Mycoprotein Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Mycoprotein Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Mycoprotein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Mycoprotein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Mycoprotein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Mycoprotein Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Mycoprotein Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Food Grade Mycoprotein
  • Feed Grade Mycoprotein
Applications
  • Meat Alternatives
  • Pet Food
  • Feed
Companies covered
  • Quorn/Monde Nissin Corporation
  • 3fbio Ltd
  • Mycorena

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mycoprotein Sales Value (2021-2032)
  4. 1.2.2 Global Mycoprotein Sales Volume (2021-2032)
  5. 1.2.3 Global Mycoprotein Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Mycoprotein Market Dynamics
  1. 2.1 Mycoprotein Industry Trends
  2. 2.2 Mycoprotein Industry Drivers
  3. 2.3 Mycoprotein Industry Opportunities and Challenges
  4. 2.4 Mycoprotein Industry Restraints
3 Mycoprotein Market by Company
  1. 3.1 Global Mycoprotein Company Revenue Ranking in 2025
  2. 3.2 Global Mycoprotein Revenue by Company (2021-2026)
  3. 3.3 Global Mycoprotein Sales Volume by Company (2021-2026)
  4. 3.4 Global Mycoprotein Average Price by Company (2021-2026)
  5. 3.5 Global Mycoprotein Company Ranking (2024-2026)
  6. 3.6 Global Mycoprotein Company Manufacturing Base and Headquarters
  7. 3.7 Global Mycoprotein Company Product Type and Application
  8. 3.8 Global Mycoprotein Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Mycoprotein Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Mycoprotein Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Mycoprotein Market by Type
  1. 4.1 Mycoprotein Type Introduction
  2. 4.1.1 Food Grade Mycoprotein
  3. 4.1.2 Feed Grade Mycoprotein
  4. 4.2 Global Mycoprotein Sales Volume by Type
  5. 4.2.1 Global Mycoprotein Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mycoprotein Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Mycoprotein Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Mycoprotein Sales Value by Type
  9. 4.3.1 Global Mycoprotein Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Mycoprotein Sales Value by Type (2021-2032)
  11. 4.3.3 Global Mycoprotein Sales Value Share by Type (2021-2032)
5 Mycoprotein Market by Application
  1. 5.1 Mycoprotein Application Introduction
  2. 5.1.1 Meat Alternatives
  3. 5.1.2 Pet Food
  4. 5.1.3 Feed
  5. 5.2 Global Mycoprotein Sales Volume by Application
  6. 5.2.1 Global Mycoprotein Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mycoprotein Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Mycoprotein Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Mycoprotein Sales Value by Application
  10. 5.3.1 Global Mycoprotein Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Mycoprotein Sales Value by Application (2021-2032)
  12. 5.3.3 Global Mycoprotein Sales Value Share by Application (2021-2032)
6 Mycoprotein Regional Sales and Value Analysis
  1. 6.1 Global Mycoprotein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mycoprotein Sales by Region (2021-2032)
  3. 6.2.1 Global Mycoprotein Sales by Region: 2021-2026
  4. 6.2.2 Global Mycoprotein Sales by Region (2027-2032)
  5. 6.3 Global Mycoprotein Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Mycoprotein Sales Value by Region (2021-2032)
  7. 6.4.1 Global Mycoprotein Sales Value by Region: 2021-2026
  8. 6.4.2 Global Mycoprotein Sales Value by Region (2027-2032)
  9. 6.5 Global Mycoprotein Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Mycoprotein Sales Value (2021-2032)
  12. 6.6.2 North America Mycoprotein Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Mycoprotein Sales Value (2021-2032)
  15. 6.7.2 Europe Mycoprotein Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Mycoprotein Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Mycoprotein Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Mycoprotein Sales Value (2021-2032)
  21. 6.9.2 South America Mycoprotein Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Mycoprotein Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Mycoprotein Sales Value Share by Country, 2025 VS 2032
7 Mycoprotein Country-level Sales and Value Analysis
  1. 7.1 Global Mycoprotein Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mycoprotein Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Mycoprotein Sales by Country (2021-2032)
  4. 7.3.1 Global Mycoprotein Sales by Country (2021-2026)
  5. 7.3.2 Global Mycoprotein Sales by Country (2027-2032)
  6. 7.4 Global Mycoprotein Sales Value by Country (2021-2032)
  7. 7.4.1 Global Mycoprotein Sales Value by Country (2021-2026)
  8. 7.4.2 Global Mycoprotein Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Mycoprotein Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Mycoprotein Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Mycoprotein Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Mycoprotein Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Mycoprotein Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Mycoprotein Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Mycoprotein Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Mycoprotein Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Mycoprotein Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Mycoprotein Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Mycoprotein Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Mycoprotein Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Mycoprotein Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Mycoprotein Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Mycoprotein Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Mycoprotein Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Mycoprotein Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Mycoprotein Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Mycoprotein Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Mycoprotein Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Mycoprotein Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Mycoprotein Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Mycoprotein Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Mycoprotein Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Mycoprotein Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Mycoprotein Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Mycoprotein Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Mycoprotein Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Mycoprotein Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Mycoprotein Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Mycoprotein Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Mycoprotein Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Mycoprotein Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Mycoprotein Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Mycoprotein Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Mycoprotein Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Mycoprotein Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Mycoprotein Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Mycoprotein Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Mycoprotein Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Mycoprotein Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Mycoprotein Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Mycoprotein Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Mycoprotein Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Mycoprotein Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Mycoprotein Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Mycoprotein Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Mycoprotein Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Mycoprotein Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Mycoprotein Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Mycoprotein Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Mycoprotein Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Mycoprotein Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Mycoprotein Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Mycoprotein Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Mycoprotein Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Mycoprotein Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Mycoprotein Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Mycoprotein Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Mycoprotein Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Mycoprotein Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Mycoprotein Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Mycoprotein Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Mycoprotein Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Mycoprotein Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Mycoprotein Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Mycoprotein Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Mycoprotein Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Mycoprotein Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Mycoprotein Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Mycoprotein Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Mycoprotein Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Mycoprotein Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Mycoprotein Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Mycoprotein Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Mycoprotein Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Mycoprotein Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Mycoprotein Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Mycoprotein Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Mycoprotein Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Mycoprotein Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Mycoprotein Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Mycoprotein Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Mycoprotein Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Quorn/Monde Nissin Corporation
  2. 8.1.1 Quorn/Monde Nissin Corporation Company Information
  3. 8.1.2 Quorn/Monde Nissin Corporation Business Overview
  4. 8.1.3 Quorn/Monde Nissin Corporation Mycoprotein Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Quorn/Monde Nissin Corporation Mycoprotein Product Portfolio
  6. 8.1.5 Quorn/Monde Nissin Corporation Recent Developments
  7. 8.2 3fbio Ltd
  8. 8.2.1 3fbio Ltd Company Information
  9. 8.2.2 3fbio Ltd Business Overview
  10. 8.2.3 3fbio Ltd Mycoprotein Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 3fbio Ltd Mycoprotein Product Portfolio
  12. 8.2.5 3fbio Ltd Recent Developments
  13. 8.3 Mycorena
  14. 8.3.1 Mycorena Company Information
  15. 8.3.2 Mycorena Business Overview
  16. 8.3.3 Mycorena Mycoprotein Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mycorena Mycoprotein Product Portfolio
  18. 8.3.5 Mycorena Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mycoprotein Value Chain Analysis
  2. 9.1.1 Mycoprotein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mycoprotein Sales Mode & Process
  6. 9.2 Mycoprotein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mycoprotein Distributors
  9. 9.2.3 Mycoprotein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst